Prescription to practice in hypertension: a community experience in central Kerala

Authors

  • Elsheba Mathew Department of Community Medicine, Pushpagiri Institute of Medical Science, Tiruvalla, Pathanamthitta, Kerala, India
  • Rajalakshmy Aiyappan Department of Community Medicine, Pushpagiri Institute of Medical Science, Tiruvalla, Pathanamthitta, Kerala, India
  • Mili M. Department of Community Medicine, Pushpagiri Institute of Medical Science, Tiruvalla, Pathanamthitta, Kerala, India
  • Navaneetha N. Department of Community Medicine, Pushpagiri Institute of Medical Science, Tiruvalla, Pathanamthitta, Kerala, India
  • Priyanka Shibu Department of Community Medicine, Pushpagiri Institute of Medical Science, Tiruvalla, Pathanamthitta, Kerala, India
  • Rajeev Aravindakshan Department of Community Medicine, Pushpagiri Institute of Medical Science, Tiruvalla, Pathanamthitta, Kerala, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20174929

Keywords:

Adherence, Barriers to adherence, Hypertension

Abstract

Background: Control of blood pressure is a global challenge and non-adherence to hypertension medications is a public health concern. Patient, medication and system related factors can contribute to non-adherence. The study was to determine adherence to hypertension medications and to understand the barriers to adherence in an adult group in Pathanamthitta District of Central Kerala.

Methods: A cross sectional study was conducted in a community setting in 2016, among 139 adults aged 30 years and above on treatment for hypertension for at least six months. Those with gestational hypertension, those having serious comorbid conditions and those unwilling to participate were excluded. The data sheet included basic demographic information and history related to hypertension. A content validated eight item questionnaire was used to assess reported adherence and scores classified level of adherence as good (8), moderate (6-<8) and poor (<6). The data was analyzed using SPSS. Chi square test of significance and multivariate regression analysis were done. P<0.05 was considered statistically significant.

Results: The participants were in the age group 34-91 years, 50.4% belonging to 50-69 years, and 75.5% were females. Adherence to hypertension medications was good in 49.6%, moderate in 31.7% and poor in 18.7%. The most common factors reported to contribute to non-adherence were forgetfulness (70.5%), high cost of medications (51.8%), and symptom-free state (27.3%).

Conclusions: Adherence was good in less than half the study participants and poor in almost one-fifth. Forgetfulness and high medication costs were the most commonly reported barriers. These findings highlight the importance of individuals, families and health service, joining hands to tackle the public health problem of non-adherence to hypertension medications.

Author Biography

Mili M., Department of Community Medicine, Pushpagiri Institute of Medical Science, Tiruvalla, Pathanamthitta, Kerala, India

postgraduate, Department of community medicine

References

Mohan V, Seedat YK, Pradeepa R. The Rising Burden of Diabetes and Hypertension in Southeast Asian and African Regions: Need for Effective Strategies for Prevention and Control in Primary Health Care Settings. Int J Hypertens. 2013;2013:e409083.

World Health Organisation | Raised blood pressure. WHO. Available from: http://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/.

Salaudeen AG, Musa OI, Babatunde OA, Atoyebi OA, Durowade KA, Omokanye LO. Knowledge and prevalence of risk factors for arterial hypertension and blood pressure pattern among bankers and traffic wardens in Ilorin, Nigeria. Afric Heal Sci. 2014;14(3):593-9.

Kerala Health Statistics, Public Health Status of Kerala. Indus Health Plus. Available from: http://www.indushealthplus.com/kerala-health-statistics.html.

Medication adherence among hypertensive patients of primary health clinics in Malaysia. Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437910/.

Kelly C. Lee. Improving medication adherence in patients with severe mental illness. Pharm Today. 2013 Jun;19(6):69–80.

EI-Hadiyah TM, Mustafa Madani A, Abdelrahim HM, Khidir Yousif A. Factors Affecting Medication Non- Adherence in Type 2 Sudanese Diabetic Patients. Pharmacol Amp Pharm. 2016;07(04):141–6

Barreto MD, Reiners AA, Marcon SS. Knowledge about hypertension and factors associated with the non-adherence to drug therapy. Revista latino-americana de enfermagem. 2014;22(3):491-8.

Dennis T, Meera NK, Binny K, Sekhar MS, Kishore G, Sasidharan S. Medication adherence and associated barriers in hypertension management in India. CVD Prev Control. 2011 Jan;6(1):9–13.

Kumaraswamy R, Kauser M, Jagadeesh Mk, Kumar Ru, Afreen A, Vagesh Kumar S, et al. Study of determinants of nonadherence to anti-hypertensive medications in essential hypertension at a Teaching Hospital in Southern India. CHRISMED J Health Res. 2015;2(1):57.

Control of Hypertension Among Adults — National Health and Nutrition Examination Survey, United States,2005–2008. Availablefrom: https://www.cdc. gov/mmwr/preview/mmwrhtml/su6102a4.htm.

Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, Ishaq M, Ambreen A, Ahmad U. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PloS one. 2007;2(3):e280.

Venkatachalam J, Abrahm SB, Singh Z, Stalin P, Sathya GR. Determinants of Patient’s Adherence to Hypertension Medications in a Rural Population of Kancheepuram District in Tamil Nadu, South India. Indian J Community Med Off Publ Indian Assoc Prev Soc Med. 2015;40(1):33–7.

Leverette ML. Effectiveness of a Medication Reminder Device in the form of a Mobile Application to Improve Medication Adherence for Patients with Hypertension. Brandman University; 2016. Available from: http://search.proquest.com/ openview/0379bce1986bc7a2d2d41d907b7f021e/1?pq-origsite=gscholar&cbl=18750&diss=y.

Morisky DE, Costa FA. The 8-item Morisky Medication Adherence Scale: Validation of a Brazilian–Portuguese version in hypertensive adults.

Okello S, Nasasira B, Muiru AN, Muyingo A. Validity and Reliability of a Self-Reported Measure of Antihypertensive Medication Adherence in Uganda. PloS one. 2016;11(7):e0158499.

Sabaté E, editor. Adherence to long-term therapies: evidence for action. World Health Organization; 2003. Available from: http://apps.who.int/medicine docs/en/d/Js4883e/8.7.4.html#Js4883e.8.7.4.

Khan MU, Shah S, Hameed T. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. J Pharm Bioallied Sci. 2014 Apr;6(2):104–8.

Ambaw AD, Alemie GA, W/Yohannes SM, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 2012;12:282.

Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan. PLOS ONE. 2007;2(3):e280.

Nair KV, Belletti DA, Doyle JJ, Allen RR, McQueen RB, Saseen JJ, et al. Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey. Patient Prefer Adherence. 2011;5:195–206.

Tong X, Chu EK, Fang J, Wall HK, Ayala C. Nonadherence to Antihypertensive Medication Among Hypertensive Adults in the United States─HealthStyles, 2010. J Clin Hypertens Greenwich Conn. 2016;18(9):892–900.

Downloads

Published

2017-10-27

How to Cite

Mathew, E., Aiyappan, R., M., M., N., N., Shibu, P., & Aravindakshan, R. (2017). Prescription to practice in hypertension: a community experience in central Kerala. International Journal of Research in Medical Sciences, 5(11), 4832–4839. https://doi.org/10.18203/2320-6012.ijrms20174929

Issue

Section

Original Research Articles